Jacob P van Vloten (Jacob van Vloten)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Pulmonary Embolism

Electronic Health Record

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Evgin, Tim Kottke, Jason Tonne, Jill Thompson, Amanda L Huff, Jacob P van Vloten, Madelyn Moore, Josefine Michael, Christopher B Driscoll, Jose Pulido, Eric Swanson, Richard B Kennedy, Matthew Coffey, Houra Loghmani, Luis Sanchez-Perez, Gloria R Olivier, Kevin J Harrington, Hardev Pandha, Alan A Melcher, Rosa Maria Diaz, Richard G Vile
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Science translational medicine 14 (640) (2022)
Timothy Kottke, Jason Tonne, Laura Evgin, Christopher B Driscoll, Jacob P van Vloten, Victoria A Jennings, Amanda L Huff, Brady Zell, Jill M Thompson, Phonphimon Wongthida, Jose Pulido, Matthew R Schuelke, Adel Samson, Peter Selby, Elizabeth J Ilett, Mark McNiven, Lewis Rowland Roberts, Mitesh J Borad, Hardev Pandha, Kevin J Harrington, Alan Melcher, Richard G Vile
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature communications 12 (1) (2021)
Kathy Matuszewska, Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, Pierre P Major, Jack Lawler, Sarah K Wootton, Byram W Bridle, Jim Petrik
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (5) (2018)